Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Long-Term Debt Repayments (2019)

Avanos Medical (AVNS) has disclosed Long-Term Debt Repayments for 4 consecutive years, with $200000.0 as the latest value for Q3 2019.

  • Quarterly Long-Term Debt Repayments changed N/A to $200000.0 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $400000.0 through Dec 2019, changed N/A year-over-year, with the annual reading at $4.7 million for FY2023, 96.29% down from the prior year.
  • Long-Term Debt Repayments hit $200000.0 in Q3 2019 for Avanos Medical, roughly flat from $200000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $50.0 million in Q2 2015 to a low of $200000.0 in Q2 2019.